MedPath

PENBRITIN CAP 250MG

PENBRITIN CAP 250MG

Discontinued
DIN Number

00002003

Drug Class

Human

Market Date

Dec 31, 1962

Company
HC

ayerst laboratories

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00002003
AIG Number0105872002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01CA01 AMPICILLIN
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification08:12.16.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

AMPICILLINActive
Strength: 250 MG / CAP
Monograph: AMPICILLIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.